U.S. IVD & LDT For Autoimmune Diseases Market Size, Share & Trends Analysis Report By Application (Ankylosing Spondylitis, Alopecia Areata, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Systemic Sclerosis, Psoriasis), By Technology, And Segment Forecasts, 2018 - 2024

Market Segments

• U.S. IVD and LDT for Autoimmune Diseases, Application Outlook (Revenue, USD Million, 2013 – 2024)

  • Addison’s Disease

  • Ankylosing Spondylitis

  • Alopecia Areata

  • Rheumatoid Arthritis

  • Systemic Lupus Erythematosus

  • Systemic Sclerosis

  • Psoriasis

  • Antiphospholipid Antibody Syndrome

  • Diabetes Type 1

  • Crohn’s Disease

  • Ulcerative Colitis

  • Narcolepsy

  • Multiple Sclerosis

  • Uveitis

  • Others

• U.S. IVD and LDT for Autoimmune Diseases, Technology Outlook (Revenue, USD Million, 2013 - 2024)

  • Immunoassays

  • Clinical Chemistry

  • Hematology

  • Coagulation

  • Microbiology

  • Molecular Diagnostics

• U.S. IVD and LDT for Autoimmune Diseases, Regional Outlook (Revenue, USD Million, 2013 - 2024)

  • North America

    • The U.S.

    • Canada

  • Europe

    • Germany

    • UK

  • Asia Pacific

    • Japan

    • China

  • Latin America

    • Brazil

    • Mexico

  • Middle East and Africa

    • South Africa

Report Content

Qualitative Analysis

• Industry overview
• Industry trends
• Market drivers and restraints
• Market size
• Growth prospects
• Porter’s analysis
• PESTEL analysis
• Key market opportunities prioritized
• Competitive landscape
  • Company overview
  • Financial performance
  • Product benchmarking
  • Latest strategic developments 

Quantitative Analysis

• Market size, estimates, and forecast from 2013 to 2024
• Revenue estimates for technology up to 2024
• Revenue estimates for type up to 2024
• Revenue estimates for application up to 2024
• Regional market size and forecast for product up to 2024